549 related articles for article (PubMed ID: 27494902)
1. MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2.
Li YL; Wang J; Zhang CY; Shen YQ; Wang HM; Ding L; Gu YC; Lou JT; Zhao XT; Ma ZL; Jin YX
Oncotarget; 2016 Sep; 7(37):59287-59298. PubMed ID: 27494902
[TBL] [Abstract][Full Text] [Related]
2. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).
He X; Chen SY; Yang Z; Zhang J; Wang W; Liu MY; Niu Y; Wei XM; Li HM; Hu WN; Sun GG
J Exp Clin Cancer Res; 2018 Sep; 37(1):230. PubMed ID: 30227870
[TBL] [Abstract][Full Text] [Related]
3. LncRNA HOTAIR Regulates CCND1 and CCND2 Expression by Sponging miR-206 in Ovarian Cancer.
Chang L; Guo R; Yuan Z; Shi H; Zhang D
Cell Physiol Biochem; 2018; 49(4):1289-1303. PubMed ID: 30205383
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA JPX correlates with poor prognosis and tumor progression in non-small-cell lung cancer by interacting with miR-145-5p and CCND2.
Jin M; Ren J; Luo M; You Z; Fang Y; Han Y; Li G; Liu H
Carcinogenesis; 2020 Jul; 41(5):634-645. PubMed ID: 31253987
[TBL] [Abstract][Full Text] [Related]
5. MiR-646 suppresses proliferation and metastasis of non-small cell lung cancer by repressing FGF2 and CCND2.
Wang J; Shu H; Guo S
Cancer Med; 2020 Jun; 9(12):4360-4370. PubMed ID: 32347652
[TBL] [Abstract][Full Text] [Related]
6. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
[TBL] [Abstract][Full Text] [Related]
7. MiR-106b-5p Promotes Proliferation and Inhibits Apoptosis by Regulating BTG3 in Non-Small Cell Lung Cancer.
Wei K; Pan C; Yao G; Liu B; Ma T; Xia Y; Jiang W; Chen L; Chen Y
Cell Physiol Biochem; 2017; 44(4):1545-1558. PubMed ID: 29197876
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
[TBL] [Abstract][Full Text] [Related]
9. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
[TBL] [Abstract][Full Text] [Related]
10. miR-615 Inhibits Prostate Cancer Cell Proliferation and Invasion by Directly Targeting Cyclin D2.
Huang F; Zhao H; Du Z; Jiang H
Oncol Res; 2019 Feb; 27(3):293-299. PubMed ID: 29471894
[TBL] [Abstract][Full Text] [Related]
11. LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis.
Chen N; Yin D; Lun B; Guo X
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30429236
[TBL] [Abstract][Full Text] [Related]
12. miR-296-5p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancer.
Xu C; Li S; Chen T; Hu H; Ding C; Xu Z; Chen J; Liu Z; Lei Z; Zhang HT; Li C; Zhao J
Oncol Rep; 2016 Jan; 35(1):497-503. PubMed ID: 26549165
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of miR-499-5p inhibits non-small cell lung cancer proliferation and metastasis by targeting VAV3.
Li M; Zhang S; Wu N; Wu L; Wang C; Lin Y
Sci Rep; 2016 Mar; 6():23100. PubMed ID: 26972445
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-490-5P Targets CCND1 to Suppress Cellular Proliferation in Glioma Cells and Tissue Through Cell Cycle Arrest.
Zhao L; Tang X; Luo R; Duan J; Wang Y; Yang B
Curr Neurovasc Res; 2018; 15(3):246-255. PubMed ID: 30101705
[TBL] [Abstract][Full Text] [Related]
15. Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/β-catenin signaling in non-small-cell lung cancer.
Zhao M; Xu P; Liu Z; Zhen Y; Chen Y; Liu Y; Fu Q; Deng X; Liang Z; Li Y; Lin X; Fang W
Cell Death Dis; 2018 Jan; 9(2):78. PubMed ID: 29362431
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer.
Kong R; Liu W; Guo Y; Feng J; Cheng C; Zhang X; Ma Y; Li S; Jiang J; Zhang J; Qiao Z; Qin J; Lu T; He X
Oncol Rep; 2017 Oct; 38(4):2572-2580. PubMed ID: 28849232
[TBL] [Abstract][Full Text] [Related]
17. miR-466 Contributes to the Enhanced Antitumor Effect of Bortezomib on Non-Small-Cell Lung Cancer by Inhibiting CCND1.
Wang WH; Zhan JM; Tang YL; Zhou N; Liu WY; Jiang DW
Chemotherapy; 2022; 67(2):110-122. PubMed ID: 35042223
[TBL] [Abstract][Full Text] [Related]
18. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
19. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
[TBL] [Abstract][Full Text] [Related]
20. Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer.
Shao Y; Shen YQ; Li YL; Liang C; Zhang BJ; Lu SD; He YY; Wang P; Sun QL; Jin YX; Ma ZL
Oncotarget; 2016 Jun; 7(23):34011-21. PubMed ID: 27049724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
